BioCentury
ARTICLE | Clinical News

Fluocinolone acetonide intravitreal implan: Phase III started

July 15, 2013 7:00 AM UTC

pSivida began a single-blind, sham-controlled, international Phase III trial to evaluate 0.18 mg fluocinolone acetonide intravitreal implant in 120 patients with recurrent non-infectious uveitis affec...